Abstract 3597: Direct targeting of KRASG12X mutant cancers with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor

Name: Work Video:
Duration: 3 min 30 s
Elena S. Koltun; Meghan A. Rice; W. Clay Gustafson; David Wilds; Jingjing Jiang; Bianca J. Lee; Zhengping Wang; Stephanie Chang; Mike Flagella; Yunming Mu; Nuntana Dinglasan; Nicole Nasholm; James Evans; Yingyun Wang; Kyle J. Seamon; Yang Liu; Cristina Blaj; John E. Knox; Rebecca Freilich; Elsa Quintana; Jim Cregg; Alun Bermingham; Adrian L. Gill; Jacqueline AM Smith; Mallika Singh
{'id': 'https://openalex.org/W4282963158', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-3597', 'title': 'Abstract 3597: Direct targeting of KRASG12X mutant cancers with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor', 'display_name': 'Abstract 3597: Direct targeting of KRASG12X mutant cancers with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor', 'publication_year': 2022, 'publication_date': '2022-06-15', 'ids': {'openalex': 'https://openalex.org/W4282963158', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-3597'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-3597', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5040036103', 'display_name': 'Elena S. Koltun', 'orcid': 'https://orcid.org/0009-0005-8720-9097'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elena S. Koltun', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053936114', 'display_name': 'Meghan A. Rice', 'orcid': 'https://orcid.org/0000-0003-4578-0461'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Meghan A. Rice', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082896068', 'display_name': 'W. Clay Gustafson', 'orcid': 'https://orcid.org/0000-0002-1812-5675'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'W. Clay Gustafson', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048487314', 'display_name': 'David Wilds', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David Wilds', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101768843', 'display_name': 'Jingjing Jiang', 'orcid': 'https://orcid.org/0000-0002-5646-6040'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jingjing Jiang', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090760997', 'display_name': 'Bianca J. Lee', 'orcid': 'https://orcid.org/0009-0000-4888-8684'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bianca J. Lee', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102845474', 'display_name': 'Zhengping Wang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Zhengping Wang', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069084946', 'display_name': 'Stephanie Chang', 'orcid': 'https://orcid.org/0009-0000-2026-5215'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Stephanie Chang', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002591487', 'display_name': 'Mike Flagella', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mike Flagella', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112876325', 'display_name': 'Yunming Mu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yunming Mu', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042229593', 'display_name': 'Nuntana Dinglasan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nuntana Dinglasan', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011524529', 'display_name': 'Nicole Nasholm', 'orcid': 'https://orcid.org/0000-0002-5451-4985'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nicole Nasholm', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029071777', 'display_name': 'James Evans', 'orcid': 'https://orcid.org/0000-0002-6414-528X'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James W. Evans', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035790788', 'display_name': 'Yingyun Wang', 'orcid': 'https://orcid.org/0009-0006-6917-0245'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yingyun Wang', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039694843', 'display_name': 'Kyle J. Seamon', 'orcid': 'https://orcid.org/0009-0005-5028-3752'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kyle Seamon', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100355773', 'display_name': 'Yang Liu', 'orcid': 'https://orcid.org/0000-0002-0367-8189'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yang Liu', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078182587', 'display_name': 'Cristina Blaj', 'orcid': 'https://orcid.org/0000-0003-0449-2690'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Cristina Blaj', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041603099', 'display_name': 'John E. Knox', 'orcid': 'https://orcid.org/0009-0006-6246-5198'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John Knox', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058039666', 'display_name': 'Rebecca Freilich', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rebecca Freilich', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023590155', 'display_name': 'Elsa Quintana', 'orcid': 'https://orcid.org/0000-0002-4123-1695'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elsa Quintana', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078573857', 'display_name': 'Jim Cregg', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jim Cregg', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071778044', 'display_name': 'Alun Bermingham', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Alun Bermingham', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022776516', 'display_name': 'Adrian L. Gill', 'orcid': 'https://orcid.org/0009-0003-0914-4860'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Adrian L. Gill', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031420872', 'display_name': 'Jacqueline AM Smith', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jacqueline Am Smith', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5057362852', 'display_name': 'Mallika Singh', 'orcid': 'https://orcid.org/0009-0003-0234-1589'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mallika Singh', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 3.469, 'has_fulltext': False, 'cited_by_count': 27, 'citation_normalized_percentile': {'value': 0.999981, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '82', 'issue': '12_Supplement', 'first_page': '3597', 'last_page': '3597'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12620', 'display_name': 'Signaling Pathways in Disease', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12620', 'display_name': 'Signaling Pathways in Disease', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12835', 'display_name': 'FOXO transcription factor regulation', 'score': 0.9918, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 0.9871, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2781187634', 'wikidata': 'https://www.wikidata.org/wiki/Q20969980', 'display_name': 'KRAS', 'level': 4, 'score': 0.744443}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.6754448}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.47023007}, {'id': 'https://openalex.org/C2776131300', 'wikidata': 'https://www.wikidata.org/wiki/Q423111', 'display_name': 'Vemurafenib', 'level': 4, 'score': 0.4411094}, {'id': 'https://openalex.org/C57074206', 'wikidata': 'https://www.wikidata.org/wiki/Q14197552', 'display_name': 'MAPK/ERK pathway', 'level': 3, 'score': 0.43084598}, {'id': 'https://openalex.org/C2781249067', 'wikidata': 'https://www.wikidata.org/wiki/Q17142288', 'display_name': 'MEK inhibitor', 'level': 4, 'score': 0.42838496}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.40368763}, {'id': 'https://openalex.org/C184235292', 'wikidata': 'https://www.wikidata.org/wiki/Q421851', 'display_name': 'Kinase', 'level': 2, 'score': 0.391687}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.35785258}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.35642153}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.3110593}, {'id': 'https://openalex.org/C2777658100', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Melanoma', 'level': 2, 'score': 0.26091638}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.19144487}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.15697402}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C2994587330', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Metastatic melanoma', 'level': 3, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-3597', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.57}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4223510352', 'https://openalex.org/W3005630266', 'https://openalex.org/W2571465038', 'https://openalex.org/W2493373689', 'https://openalex.org/W2487850446', 'https://openalex.org/W2320994390', 'https://openalex.org/W2219112405', 'https://openalex.org/W2109132296', 'https://openalex.org/W2023835753', 'https://openalex.org/W1453870474'], 'abstract_inverted_index': {'Abstract': [0], 'Mutant': [1], 'RAS': [2, 86, 117, 149], 'is': [3, 67], 'common': [4], 'in': [5, 21, 101, 133, 140, 156, 160, 164, 195, 216, 239, 263, 278, 293, 306, 322, 329], 'pancreatic': [6], 'carcinoma': [7], '(PDAC),': [8], 'non-small': [9], 'cell': [10, 128, 138, 197], 'lung': [11], 'cancer': [12, 16, 137], '(NSCLC)': [13], 'and': [14, 18, 63, 127, 130, 145, 171, 191, 200, 209, 226, 251, 265, 275, 319], 'colorectal': [15], '(CRC)': [17], 'exists': [19], 'predominantly': [20], 'the': [22, 303, 314, 415], 'GTP-bound': [23], '(RAS(ON))': [24], 'state,': [25], 'leading': [26], 'to': [27, 78, 91, 108, 119, 122, 153, 169, 183], 'excessive': [28], 'downstream': [29], 'oncogenic': [30, 288], 'signaling.': [31], 'KRASG12C(OFF)': [32], 'inhibitors': [33], 'have': [34], 'provided': [35], 'clinical': [36, 325], 'proof': [37], 'of': [38, 48, 85, 148, 181, 247, 308, 316, 327, 397, 414], 'concept': [39], 'for': [40, 418], 'targeting': [41, 396], 'mutant': [42, 221, 281, 299, 399], 'KRAS.': [43], 'Preclinical': [44], 'data': [45], 'suggests': [46], 'inhibition': [47, 235], 'RAS(ON)': [49, 107], 'may': [50], 'be': [51], 'a': [52, 68, 83, 102, 110, 253, 279, 294, 403], 'superior': [53], 'therapeutic': [54], 'strategy.': [55], 'In': [56], 'addition,': [57], 'KRASG12': [58], 'mutations': [59], 'such': [60], 'as': [61], 'KRASG12D': [62], 'KRASG12V': [64], 'remain': [65], 'unserved.RMC-6236': [66], 'first-in-class,': [69, 404], 'potent,': [70], 'oral': [71], 'tri-complex': [72, 113, 408], 'RASMULTI(ON)': [73, 409], 'small': [74], 'molecule': [75], 'inhibitor': [76, 410], 'designed': [77], 'treat': [79], 'cancers': [80, 400], 'driven': [81], 'by': [82, 177], 'variety': [84], 'mutations.': [87], 'RMC-6236': [88, 123, 182, 248, 285, 328], 'non-covalently': [89], 'binds': [90], 'an': [92], 'abundant': [93], 'intracellular': [94], 'chaperone': [95], 'protein,': [96], 'cyclophilin': [97], 'A': [98], '(CypA),': [99], 'resulting': [100], 'binary': [103], 'complex': [104], 'that': [105, 114, 241], 'engages': [106], 'form': [109], 'high-affinity,': [111], 'RAS-selective': [112], 'sterically': [115], 'inhibits': [116], 'binding': [118, 180], 'effectors.': [120], 'Exposure': [121], 'suppressed': [124], 'ERK': [125], 'phosphorylation': [126], 'growth,': [129], 'induced': [131, 142, 189], 'apoptosis': [132], 'multiple': [134, 196], 'human': [135], 'RAS-addicted': [136], 'lines': [139], 'vitro.RMC-6236': [141], 'dose-dependent,': [143], 'deep,': [144], 'durable': [146, 192, 237, 272], 'suppression': [147], 'pathway': [150], 'activation': [151], 'up': [152], '48': [154], 'hours': [155], 'preclinical': [157, 311], 'xenograft': [158, 204], 'models': [159], 'vivo.': [161], 'Prolonged': [162], 'exposure': [163], 'tumors': [165, 240], 'was': [166, 213, 236, 249, 266], 'observed': [167], 'relative': [168], 'blood': [170], 'various': [172], 'healthy': [173], 'tissues,': [174], 'likely': [175], 'mediated': [176], 'high': [178], 'affinity': [179], 'tumor': [184, 193, 230, 304], 'CypA.RMC-6236': [185], 'at': [186], 'tolerable': [187], 'doses': [188], 'profound': [190], 'regressions': [194, 231], 'line-derived': [198], '(CDX)': [199], 'patient-derived': [201], '(PDX)': [202], 'RASMUT': [203], 'models,': [205], 'including': [206], 'NSCLC,': [207, 317], 'CRC': [208, 282, 320], 'PDAC.': [210], 'Anti-tumor': [211], 'activity': [212], 'particularly': [214, 223], 'notable': [215], 'KRAS': [217, 280, 298], 'position': [218], '12': [219], '(G12X)': [220], 'tumors,': [222], 'KRASG12D,': [224], 'KRASG12V,': [225], 'KRASG12R,': [227], 'with': [228, 268, 331, 401], 'significant': [229], 'observed.': [232], 'Tumor': [233], 'growth': [234], 'even': [238], 'did': [242], 'not': [243], 'regress.': [244], 'Intermittent': [245], 'scheduling': [246], 'active': [250], 'permitted': [252], 'higher': [254], 'dose': [255], 'intensity': [256], 'than': [257], 'daily': [258], 'dosing.RMC-6236': [259], 'promoted': [260], 'anti-tumor': [261, 309], 'immunity': [262], 'vivo': [264], 'additive': [267], 'anti-PD1': [269], 'antibodies,': [270], 'driving': [271], 'complete': [273], 'responses': [274], 'immunologic': [276], 'memory': [277], 'model.': [283], 'Furthermore,': [284], 'treatment': [286], 'reversed': [287], 'RAS-driven': [289], 'immune': [290], 'evasion': [291], 'mechanisms': [292], 'checkpoint': [295], 'blockade': [296], 'refractory': [297], 'model,': [300], 'significantly': [301], 'transforming': [302], 'microenvironment': [305], 'favor': [307], 'immunity.These': [310], 'results': [312], 'support': [313], 'inclusion': [315], 'PDAC,': [318], 'patients': [321, 330], 'our': [323], 'planned': [324], 'trial': [326], 'KRASG12X': [332, 398], 'advanced': [333], 'solid': [334], 'tumors.': [335], 'Citation': [336], 'Format:': [337], 'Elena': [338], 'S.': [339], 'Koltun,': [340], 'Meghan': [341], 'A.': [342], 'Rice,': [343], 'W.': [344, 367], 'Clay': [345], 'Gustafson,': [346], 'David': [347], 'Wilds,': [348], 'Jingjing': [349], 'Jiang,': [350], 'Bianca': [351], 'J.': [352], 'Lee,': [353], 'Zhengping': [354], 'Wang,': [355, 370], 'Stephanie': [356], 'Chang,': [357], 'Mike': [358], 'Flagella,': [359], 'Yunming': [360], 'Mu,': [361], 'Nuntana': [362], 'Dinglasan,': [363], 'Nicole': [364], 'Nasholm,': [365], 'James': [366], 'Evans,': [368], 'Yingyun': [369], 'Kyle': [371], 'Seamon,': [372], 'Yang': [373], 'Liu,': [374], 'Cristina': [375], 'Blaj,': [376], 'John': [377], 'Knox,': [378], 'Rebecca': [379], 'Freilich,': [380], 'Elsa': [381], 'Quintana,': [382], 'Jim': [383], 'Cregg,': [384], 'Alun': [385], 'Bermingham,': [386], 'Adrian': [387], 'L.': [388], 'Gill,': [389], 'Jacqueline': [390], 'Am': [391], 'Smith,': [392], 'Mallika': [393], 'Singh.': [394], 'Direct': [395], 'RMC-6236,': [402], 'RAS-selective,': [405], 'orally': [406], 'bioavailable,': [407], '[abstract].': [411], 'In:': [412], 'Proceedings': [413], 'American': [416], 'Association': [417], 'Cancer': [419, 430], 'Research': [420], 'Annual': [421], 'Meeting': [422], '2022;': [423], '2022': [424], 'Apr': [425], '8-13.': [426], 'Philadelphia': [427], '(PA):': [428], 'AACR;': [429], 'Res': [431], '2022;82(12_Suppl):Abstract': [432], 'nr': [433], '3597.': [434]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4282963158', 'counts_by_year': [{'year': 2024, 'cited_by_count': 10}, {'year': 2023, 'cited_by_count': 10}, {'year': 2022, 'cited_by_count': 6}], 'updated_date': '2024-12-15T14:50:19.358756', 'created_date': '2022-06-17'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
